• EQT makes $2.8 bn bid for Recipharm expresspharma
    December 15, 2020
    EQT said it was bidding 220 crowns per Recipharm share, a 22.9 per cent premium to Recipharm’s closing price.
  • EQT increases offer for Karo Pharma to $694m pharmaceutical-technology
    January 04, 2019
    Private investment firm EQT has increased its offer for Sweden-based Karo Pharma to Skr6.15bn ($694m), partly due to an improved stock market performance since its initial bid more than two months ago......
PharmaSources Customer Service